AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on October 19, 2026

AMERICAN SWISS FOUNDATION ANNOUNCES THE CLASS OF 2026 - 2027 INNOVATION FELLOWS
Censinet Opens Enrollment for the 2027 Healthcare Cybersecurity & AI Benchmarking Study
Holiday Stress Is Rising Again This Year: A Psychologist Can Explain the Difference Between Normal and Something More
CarGurus To Report Third Quarter 2026 Financial Results
City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants
Acumen Pharmaceuticals to Report Third Quarter Financial Results on October 26, 2026
AI Disruption in IV Therapy and Vein Access: Smart Infusion, Connected Care, and Venture Capital Converge Around a High-Stakes Clinical Frontier
CSPi Technology Solutions Announces Technology Project
Cerence AI Named Growth and Innovation Index Leader in Frost Radar™ for AI-Powered In-Car Assistants
Beacon Biosignals Partners with Project Sleep to Shorten the Path to Diagnosis for People with Idiopathic Hypersomnia and Narcolepsy
ConnectM Forms Strategic Advisory Board to Drive AI Energy Infrastructure Growth; Appoints Ashland Director Ashish Kulkarni, Former Fortress and Shumway Capital Executive Neil Bhatia, and Las Olas Capital CEO Jim McCabe
Proof and Circle Show How AI Agents Can Prove Who They Act For and Pay in USDC
Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026
Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting
MKS Inc. to Sell Its Ophir® Optics Business to TTM Technologies, Inc.
Medera's Novoheart Technology Powers Advanced Human Cardiac Disease Modeling at Singapore's New CIPHER Research Centre
Biogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Week
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at IDWeek 2026
EyePoint Announces Strategic Prioritization

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.